Cargando…
Retraction: Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease
Autores principales: | Liu, Wei-Guo, Wang, Xi-Jing, Lu, Guo-Qiang, Li, Biao, Wang, Gang, Chen, Sheng-Di |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777902/ https://www.ncbi.nlm.nih.gov/pubmed/19889210 http://dx.doi.org/10.1186/1750-1326-4-45 |
Ejemplares similares
-
Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease
por: Liu, Wei-Guo, et al.
Publicado: (2007) -
Retraction: Conversion of human umbilical cord mesenchymal stem cells in Wharton’s jelly to dopamine neurons mediated by the Lmx1a and Neurturin In Vitro: Potential therapeutic application for Parkinson’s disease in a rhesus monkey model
Publicado: (2020) -
Neurturin overexpression in dopaminergic neurons induces presynaptic and postsynaptic structural changes in rats with chronic 6-hydroxydopamine lesion
por: Reyes-Corona, David, et al.
Publicado: (2017) -
Retraction: Ectopic Pregnancy-Derived Human Trophoblastic Stem Cells Regenerate Dopaminergic Nigrostriatal Pathway to Treat Parkinsonian Rats
Publicado: (2021) -
Retraction to using a deep recurrent neural network with EEG signal to detect Parkinson’s disease
por: Xu, Shixiao, et al.
Publicado: (2021)